Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;107(8):1308-1310.
doi: 10.2105/AJPH.2017.303825. Epub 2017 Jun 22.

Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons

Marian Jarlenski  1 , Colleen L Barry  1 , Sarah Gollust  1 , Amy J Graves  1 , Alene Kennedy-Hendricks  1 , Katy Kozhimannil  1
Affiliations

Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons

Marian Jarlenski et al. Am J Public Health. 2017 Aug.

Abstract

Objectives: To determine the prevalence and patterns of polysubstance use among US reproductive-aged women who use opioids for nonmedical purposes.

Methods: We used the National Survey of Drug Use and Health (2005-2014) data on female respondents aged 18 to 44 years reporting nonmedical opioid use in the past 30 days (unweighted n = 4498). We categorized patterns of polysubstance use in the past 30 days, including cigarettes, binge drinking, and other legal and illicit substances and reported prevalence adjusted for age, race/ethnicity, and educational attainment.

Results: Of all women with nonmedical opioid use, 11% reported only opioid use. Polysubstance use was highest in non-Hispanic White women and women with lower educational attainment. The most frequently used other substances among women using opioids nonmedically were cigarettes (56.2% smoked > 5 cigarettes per day), binge drinking (49.7%), and marijuana (32.4%). Polysubstance use was similarly prevalent among pregnant women with nonmedical opioid use.

Conclusions: Polysubstance use is highly prevalent among US reproductive-aged women reporting nonmedical opioid use. Public Health Implications. Interventions are needed that address concurrent use of multiple substances.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62:537–542. - PMC - PubMed
    1. King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014;104:e32–e42. - PMC - PubMed
    1. Jones HE, Martin PR, Heil SH et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35:245–259. - PMC - PubMed
    1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307:1934–1940. - PubMed
    1. Shiels MS, Chernyavskiy P, Anderson WF et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet. 2017;389(10073):1043–1054. - PMC - PubMed

Publication types

Substances